Copyright Reports & Markets. All rights reserved.

Global AI Pharmaceutical Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Pharmaceutical by Type
    • 1.3.1 Overview: Global AI Pharmaceutical Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Pharmaceutical Consumption Value Market Share by Type in 2025
    • 1.3.3 Artificial intelligence (AI)
    • 1.3.4 Machine Learning (ML)
    • 1.3.5 Others
  • 1.4 Global AI Pharmaceutical Market by Application
    • 1.4.1 Overview: Global AI Pharmaceutical Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Discovery
    • 1.4.3 Clinical Trials
    • 1.4.4 Others
  • 1.5 Global AI Pharmaceutical Market Size & Forecast
  • 1.6 Global AI Pharmaceutical Market Size and Forecast by Region
    • 1.6.1 Global AI Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global AI Pharmaceutical Market Size by Region, (2021-2032)
    • 1.6.3 North America AI Pharmaceutical Market Size and Prospect (2021-2032)
    • 1.6.4 Europe AI Pharmaceutical Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific AI Pharmaceutical Market Size and Prospect (2021-2032)
    • 1.6.6 South America AI Pharmaceutical Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa AI Pharmaceutical Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Noetik
    • 2.1.1 Noetik Details
    • 2.1.2 Noetik Major Business
    • 2.1.3 Noetik AI Pharmaceutical Product and Solutions
    • 2.1.4 Noetik AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Noetik Recent Developments and Future Plans
  • 2.2 Atomwise
    • 2.2.1 Atomwise Details
    • 2.2.2 Atomwise Major Business
    • 2.2.3 Atomwise AI Pharmaceutical Product and Solutions
    • 2.2.4 Atomwise AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Atomwise Recent Developments and Future Plans
  • 2.3 Cradle
    • 2.3.1 Cradle Details
    • 2.3.2 Cradle Major Business
    • 2.3.3 Cradle AI Pharmaceutical Product and Solutions
    • 2.3.4 Cradle AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cradle Recent Developments and Future Plans
  • 2.4 Exscientia
    • 2.4.1 Exscientia Details
    • 2.4.2 Exscientia Major Business
    • 2.4.3 Exscientia AI Pharmaceutical Product and Solutions
    • 2.4.4 Exscientia AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Exscientia Recent Developments and Future Plans
  • 2.5 Iktos
    • 2.5.1 Iktos Details
    • 2.5.2 Iktos Major Business
    • 2.5.3 Iktos AI Pharmaceutical Product and Solutions
    • 2.5.4 Iktos AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Iktos Recent Developments and Future Plans
  • 2.6 Insilico Medicine
    • 2.6.1 Insilico Medicine Details
    • 2.6.2 Insilico Medicine Major Business
    • 2.6.3 Insilico Medicine AI Pharmaceutical Product and Solutions
    • 2.6.4 Insilico Medicine AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Insilico Medicine Recent Developments and Future Plans
  • 2.7 BenevolentAI
    • 2.7.1 BenevolentAI Details
    • 2.7.2 BenevolentAI Major Business
    • 2.7.3 BenevolentAI AI Pharmaceutical Product and Solutions
    • 2.7.4 BenevolentAI AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BenevolentAI Recent Developments and Future Plans
  • 2.8 Cyclica
    • 2.8.1 Cyclica Details
    • 2.8.2 Cyclica Major Business
    • 2.8.3 Cyclica AI Pharmaceutical Product and Solutions
    • 2.8.4 Cyclica AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cyclica Recent Developments and Future Plans
  • 2.9 Recursion
    • 2.9.1 Recursion Details
    • 2.9.2 Recursion Major Business
    • 2.9.3 Recursion AI Pharmaceutical Product and Solutions
    • 2.9.4 Recursion AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Recursion Recent Developments and Future Plans
  • 2.10 Auransa
    • 2.10.1 Auransa Details
    • 2.10.2 Auransa Major Business
    • 2.10.3 Auransa AI Pharmaceutical Product and Solutions
    • 2.10.4 Auransa AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Auransa Recent Developments and Future Plans
  • 2.11 InveniAI
    • 2.11.1 InveniAI Details
    • 2.11.2 InveniAI Major Business
    • 2.11.3 InveniAI AI Pharmaceutical Product and Solutions
    • 2.11.4 InveniAI AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 InveniAI Recent Developments and Future Plans
  • 2.12 Pfizer
    • 2.12.1 Pfizer Details
    • 2.12.2 Pfizer Major Business
    • 2.12.3 Pfizer AI Pharmaceutical Product and Solutions
    • 2.12.4 Pfizer AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Pfizer Recent Developments and Future Plans
  • 2.13 IBM
    • 2.13.1 IBM Details
    • 2.13.2 IBM Major Business
    • 2.13.3 IBM AI Pharmaceutical Product and Solutions
    • 2.13.4 IBM AI Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 IBM Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Pharmaceutical Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Pharmaceutical by Company Revenue
    • 3.2.2 Top 3 AI Pharmaceutical Players Market Share in 2025
    • 3.2.3 Top 6 AI Pharmaceutical Players Market Share in 2025
  • 3.3 AI Pharmaceutical Market: Overall Company Footprint Analysis
    • 3.3.1 AI Pharmaceutical Market: Region Footprint
    • 3.3.2 AI Pharmaceutical Market: Company Product Type Footprint
    • 3.3.3 AI Pharmaceutical Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Pharmaceutical Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Pharmaceutical Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Pharmaceutical Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Pharmaceutical Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Pharmaceutical Consumption Value by Type (2021-2032)
  • 6.2 North America AI Pharmaceutical Market Size by Application (2021-2032)
  • 6.3 North America AI Pharmaceutical Market Size by Country
    • 6.3.1 North America AI Pharmaceutical Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Pharmaceutical Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Pharmaceutical Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Pharmaceutical Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Pharmaceutical Market Size by Country
    • 7.3.1 Europe AI Pharmaceutical Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Pharmaceutical Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Pharmaceutical Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Pharmaceutical Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Pharmaceutical Market Size by Region
    • 8.3.1 Asia-Pacific AI Pharmaceutical Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Pharmaceutical Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Pharmaceutical Consumption Value by Type (2021-2032)
  • 9.2 South America AI Pharmaceutical Consumption Value by Application (2021-2032)
  • 9.3 South America AI Pharmaceutical Market Size by Country
    • 9.3.1 South America AI Pharmaceutical Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Pharmaceutical Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Pharmaceutical Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Pharmaceutical Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Pharmaceutical Market Size by Country
    • 10.3.1 Middle East & Africa AI Pharmaceutical Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Pharmaceutical Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Pharmaceutical Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Pharmaceutical Market Drivers
  • 11.2 AI Pharmaceutical Market Restraints
  • 11.3 AI Pharmaceutical Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Pharmaceutical Industry Chain
  • 12.2 AI Pharmaceutical Upstream Analysis
  • 12.3 AI Pharmaceutical Midstream Analysis
  • 12.4 AI Pharmaceutical Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global AI Pharmaceutical market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global AI Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global AI Pharmaceutical market size and forecasts, in consumption value ($ Million), 2021-2032
    Global AI Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global AI Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global AI Pharmaceutical market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for AI Pharmaceutical
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global AI Pharmaceutical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Noetik, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, BenevolentAI, Cyclica, Recursion, Auransa, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    AI Pharmaceutical market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Artificial intelligence (AI)
    Machine Learning (ML)
    Others
    Market segment by Application
    Drug Discovery
    Clinical Trials
    Others
    Market segment by players, this report covers
    Noetik
    Atomwise
    Cradle
    Exscientia
    Iktos
    Insilico Medicine
    BenevolentAI
    Cyclica
    Recursion
    Auransa
    InveniAI
    Pfizer
    IBM
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe AI Pharmaceutical product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of AI Pharmaceutical, with revenue, gross margin, and global market share of AI Pharmaceutical from 2021 to 2026.
    Chapter 3, the AI Pharmaceutical competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Pharmaceutical market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of AI Pharmaceutical.
    Chapter 13, to describe AI Pharmaceutical research findings and conclusion.

    Buy now